Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma

ConclusionsEarly decline and NLR at 6  weeks are associated with significantly improved outcomes in mRCC patients treated with ICB. The prognostic value of the readily-available NLR warrants larger, prospective validation.

Source: Journal for Immunotherapy of Cancer - January 22, 2018 Category: Cancer & Oncology Source Type: research